Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (890)	1/26/1998 8:38:00 AM
From: Haolin Ni	Read Replies (2) \| Respond to of 3579

I belive that most investors know the company ZITL/MD. Dr. Chang, a Nobel prize winner scientist, is working for the MD for years to develope a Y2K program (MAP 2000). Most of the hypers used his name to hype the stock price of ZITL/MD. ZITL went from $5 to $140, now is about $22 (before splite price). ZITL/MD has no y2k contract except a test award one but no Y2k revenue yet. Great Names in advicery Board did not help GERN develped any profitable products yet.